alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 10.21

                           RICHARD R. NEITZ-TERM SHEET
                    TITLE- PRESIDENT-RETAIL PRODUCTS DIVISION

o     $250,000 ANNUAL SALARY; 3 YEAR TERM SUBJECT TO SEPARATION AND NON-COMPETE
      TERMS SIMILAR TO THAT OF PRIOR EMPLOYMENT CONTRACT WITH DSI.

o     100,000 NQSO STOCK OPTIONS AT THE CLOSING PRICE ON THE DAY MR. NEITZ
      COMMENCES EMPLOYMENT WHICH IS OCTOBER 1,1999; OPTIONS WILL VEST RATABLY
      OVER A THREE YEAR PERIOD.

o     BONUS PROGRAM-IF RETAIL EARNINGS BEFORE TAXES EXCEED $1.5 MILLION AND $2.5
      MILLION IN EACH OF THE FISCAL YEARS ENDED JULY 31,2000 AND 2001
      RESPECTIVELY, THEN MR. NEITZ WILL RECEIVE A BONUS EQUIVALENT TO 2% OF ALL
      SUCH NET EARNINGS BEFORE TAXES. ONCE $2.5 MILLION OF EARNINGS HAVE BEEN
      OBTAINED IN ANY FISCAL YEAR, THE MINIMUM TO EARN A BONUS SHALL BE
      INCREASED 20% A YEAR THEREAFTER.

o     MOVING EXPENSES-ALL OUT-OF-POCKET MOVING EXPENSES. TWO BEDROOM APARTMENT
      WHILE RELOCATING FOR A PERIOD NOT TO EXCEED 6 MONTHS.

o     VACATION- 3 WEEKS ANNUALLY, EARNED RATABLY OVER THE EMPLOYMENT TERM, AND
      NOT TO BE CARRIED FORWARD TO FUTURE YEARS.

o     HEALTH BENEFITS-SAME AS ALL EXECUTIVE OFFICERS.

o     CAR ALLOWANCE- $500 PER MONTH

o     LIFE INSURANCE-PICK UP PAYMENTS ON INSURANCE CURRENTLY BEING PAID BY DSI.

o     MEMBERSHIP TO TOY MANUFACTURERS OF AMERICA

o     CHANGE IN CONTROL- IF THERE IS A SIGNIFICANT CHANGE IN STOCK OWNERSHIP OR
      BOARD OF DIRECTORS THEN OPTIONS VEST IMMEDIATELY.

o     TRAVEL-1ST CLASS AND MAY TAKE WIFE ONE TIME ANNUALLY 1ST CLASS TO HONG
      KONG.

o     ATTORNEY FEES EXCEEDING $10,000 REGARDING SEPARATION AGREEMENT WITH DSI.

o     BOARD SEAT.

o     MOBIL PHONE USAGE SIMILAR TO EXISTING SERVICE FOR EXECUTIVES.

o     DEFINITIVE AGREEMENT TO BE NEGOTIATED.

o     COMPANY WILL HOLD MR. NEITZ HARMLESS AND INDEMNIFY ON ANY ACTION BY DSI
      TOYS AS IT PERTAINS TO MR. NEITZ AND PLAY BY PLAY TOGETHER.


------------------                            -----------------
RAYMOND BRAUN                                 RICHARD R. NEITZ
PRESIDENT AND CHIEF OPERATING OFFICER
OCTOBER 5, 1999
###### Editorial Note on Part 117

#### Editorial Note:

Nomenclature changes to part 117 appear at 81 FR 49896, July 29, 2016.

#### § 117.137 Provision of assurances required under § 117.136(a)(2), (3), and (4).

A facility that provides a written assurance under § 117.136(a)(2), (3), or (4) must act consistently with the assurance and document its actions taken to satisfy the written assurance.
#### Gerda Crute, Appellant, v. George Crute, Respondent.

In an action in which plaintiff was granted a judgment of separation on November 7, 1951, she appeals from two orders of the Supreme Court, Westchester County, as follows: (1) as limited by her brief, from so much of an order dated May 2, 1969 as, upon a cross motion by defendant, reduced the amount of alimony awarded plaintiff in the judgment from $45 a week to $15 a week; and (2) from an order dated November 10, 1969 which denied plaintiff’s subsequent motion to compel defendant to pay plaintiff’s counsel fee and printing expenses upon her appeal to this court from the order of May 2, 1969. Order dated May 2,1969 modified, on the law and the facts and in the exercise of discretion, by striking from the second decretal paragraph thereof the figure “ $15.00 ” and substituting therefor the figure “$30”. As so modified, order affirmed insofar as appealed from. Order dated November 10, 1969 reversed, on the law and the facts, and in the exercise of discretion, and plaintiff’s motion granted to the extent that defendant is directed to pay her $200 for her counsel fee upon her appeal from the order of May 2, 1969. Payment thereof shall be made within 10 days after service upon defendant of a copy of the order hereon with notice of entry. Plaintiff is awarded $20 costs and disbursements, to cover both appeals. In our opinion, defendant demonstrated an adequate change of circumstances to permit the discretionary reduction of alimony. However, the record reveals that neither plaintiff nor defendant will incur future expense for medicines, in view of their coverage by Medicare, and that plaintiff’s expenses without any allowance for entertainment or miscellaneous expenses are not even offset by her income as testified to in the record, including the reduced alimony payments as herein modified. Accordingly, we feel that it was an improvident exercise of discretion to reduce the payments to $15 per week and that the record more properly justifies a reduction to $30 per week. We are also of the opinion that it was an improvident exercise of discretion by the Special Term to deny plaintiff an award for her counsel fee for prosecution of her appeal from the order which reduced the alimony. Munder, Acting P. J., Martuseello, Latham, Kleinfeld and Benjamin, JJ., concur.
Editorial Note on Part 170
Editorial Note: Nomenclature changes to part 170 appear at 66 FR 56035, Nov. 6, 2001, and 69 FR 13717, Mar. 24, 2004.

§ 170.265 What FDA will do with a GRAS notice. ( a ) ( 1 ) We will conduct an initial evaluation of your submission to determine whether to file it as a GRAS notice for evaluation of your view that the notified substance is GRAS under the conditions of its intended use.
( 2 ) If we file your submission as a GRAS notice, we will send you a letter that informs you of the date of filing.
( 3 ) If we do not file your submission as a GRAS notice, we will send you a letter that informs you of that fact and provides our reasons for not filing the submission as a GRAS notice.
( 4 ) We will consider any timely amendment that you submit to a filed GRAS notice, to update your GRAS notice or in response to a question from us, before we respond to you by letter in accordance with paragraph (b)(1) of this section, if we deem that doing so is feasible within the timeframes established in paragraph (b) of this section. If we deem that considering your amendment is not feasible within the timeframes established in paragraph (b) of this section or if we have granted your request to cease to evaluate your notice, we will inform you that we are not considering your amendment.
( b ) ( 1 ) Within 180 days of filing, we will respond to you by letter based on our evaluation of your notice. We may extend the 180 day timeframe by 90 days on an as needed basis.
( 2 ) If we extend the timeframe, we will inform you in writing of the extension as soon as practicable but no later than within 180 days of filing.
( 3 ) If you ask us to cease to evaluate your GRAS notice in accordance with § 170.260(b), we will send you a letter informing you of our decision regarding your request.
( c ) If circumstances warrant, we will send you a subsequent letter about the notice.
###### Editorial Note on Part 172

#### Editorial Note:

Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

#### § 172.165 Quaternary ammonium chloride combination.

The food additive, quaternary ammonium chloride combination, may be safely used in food in accordance with the following conditions:

(a) The additive contains the following compounds: *n-*dodecyl dimethyl benzyl ammonium chloride (CAS Reg. No. 139-07-1); *n-*dodecyl dimethyl ethylbenzyl ammonium chloride (CAS Reg. No. 27479-28-3); *n-*hexadecyl dimethyl benzyl ammonium chloride (CAS Reg. No. 122-18-9); *n-*octadecyl dimethyl benzyl ammonium chloride (CAS Reg. No. 122-19-0); *n-*tetradecyl dimethyl benzyl ammonium chloride (CAS Reg. No. 139-08-2); *n-*tetradecyl dimethyl ethylbenzyl ammonium chloride (CAS Reg. No. 27479-29-4).

(b) The additive meets the following specifications: pH (5 percent active solution) 7.0-8.0; total amines, maximum 1 percent as combined free amines and amine hydrochlorides.

(c) The additive is used as an antimicrobial agent, as defined in § 170.3(o)(2) of this chapter, in raw sugar cane juice. It is added prior to clarification when further processing of the sugar cane juice must be delayed.

(d) The additive is applied to the sugar juice in the following quantities, based on the weight of the raw cane:

| Component | Parts per million |
| --- | --- |
| *n-*Dodecyl dimethyl benzyl ammonium chloride | 0.25-1.0 |
| *n-*Dodecyl dimethyl ethylbenzyl ammonium chloride | 3.4-13.5 |
| *n-*Hexadecyl dimethyl benzyl ammonium chloride | 1.5-6.0 |
| *n-*Octadecyl dimethyl benzyl ammonium chloride | 0.25-1.0 |
| *n-*Tetradecyl dimethyl benzyl ammonium chloride | 3.0-12.0 |
| *n-*Tetradecyl dimethyl ethylbenzyl ammonium chloride | 1.6-6.5 |

[50 FR 3890, Jan. 29, 1985]
-84 -82 -80 -78 -76 -74 -72 -70

 34

 36

 38

 40

★

▲

▲

▲

▲

★ ▲ ▲ ▲ ▲

 500

 1000

 1500

 100

18 12 06 00

05/31

NOAA HYSPLIT MODEL

 Backward trajectory ending at 2300 UTC 31 May 07

 EDAS Meteorological Data

Source

★ at 38.90 N 76.65 W Meters AGL
<PAGE>   1
                                                                    EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS




      We consent to the incorporation by reference in the Registration Statement
(Form S-8) pertaining to the 1995 SeaMED Corporation Stock Option and Incentive
Plan of our report dated August 6, 1996, with respect to the financial
statements and schedule of SeaMED Corporation included in its Registration
Statement, as amended (Form S-1 No. 333-13455) filed with the Securities and
Exchange Commission on November 18, 1996.


Seattle, Washington                                   ERNST & YOUNG LLP
July 22, 1997
Exhibit 32.2

CERTIFICATION OF CHIEF ACCOUNTING OFFICER

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

The undersigned, Kevin G. Wills, Executive Vice President and Chief Financial Officer of Saks Incorporated (the Company), has executed
this certification in connection with the filing with the Securities and Exchange Commission of the Companys Quarterly Report on Form 10-Q for the quarter ended August 2, 2008 (the Report).

The undersigned hereby certifies that:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned has executed this certification as of the 2nd day of September, 2008.



|                                                    
|----------------------------------------------------
|/s/ Kevin G. Wills                                  
|Kevin G. Wills                                      
|Executive Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Saks Incorporated
and will be retained by Saks Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.
§ 1003.20 Notification by the manufacturer to the Secretary. The notification to the Secretary required by § 1003.10(a) shall be confirmed in writing and, in addition to other relevant information which the Secretary may require, shall include the following: ( a ) Identification of the product or products involved;
( b ) The total number of such product units so produced, and the approximate number of such product units which have left the place of manufacture;
( c ) The expected usage for the product if known to the manufacturer;
( d ) A description of the defect in the product or the manner in which the product fails to comply with an applicable Federal standard;
( e ) An evaluation of the hazards reasonably related to defect or the failure to comply with the Federal standard;
( f ) A statement of the measures to be taken to repair such defect or to bring the product into compliance with the Federal standard;
( g ) The date and circumstances under which the defect was discovered; and
( h ) The identification of any trade secret information which the manufacturer desires kept confidential.
§ 200.444 General costs of government. ( a ) For states, local governments, and Indian Tribes, the general costs of government are unallowable (except as provided in § 200.475). Unallowable costs include: ( 1 ) Salaries and expenses of the Office of the Governor of a state or the chief executive of a local government or the chief executive of an Indian tribe;
( 2 ) Salaries and other expenses of a state legislature, tribal council, or similar local governmental body, such as a county supervisor, city council, school board, etc., whether incurred for purposes of legislation or executive direction;
( 3 ) Costs of the judicial branch of a government;
( 4 ) Costs of prosecutorial activities unless treated as a direct cost to a specific program if authorized by statute or regulation (however, this does not preclude the allowability of other legal activities of the Attorney General as described in § 200.435); and
( 5 ) Costs of other general types of government services normally provided to the general public, such as fire and police, unless provided for as a direct cost under a program statute or regulation.
( b ) For Indian tribes and Councils of Governments (COGs) (see definition for *Local government* in § 200.1 of this part), up to 50% of salaries and expenses directly attributable to managing and operating Federal programs by the chief executive and his or her staff can be included in the indirect cost calculation without documentation.
[78 FR 78608, Dec. 26, 2013, as amended at 79 FR 75886, Dec. 19, 2014; 85 FR 49568, Aug. 13, 2020]
EXHIBIT 11
<TABLE>
 First Health Group Corp. and Subsidiaries
 COMPUTATION OF BASIC EARNINGS PER COMMON SHARE
 (Unaudited)


                                                Three Months Ended March 31,
                                                ---------------------------
                                                   2000            1999
                                                -----------     -----------
 <S>                                           <C>             <C>
 Net income .............................      $ 19,612,000    $ 17,580,000
                                                ===========     ===========
 Weighted average number of common shares
   outstanding:

   Shares outstanding from beginning of period   47,656,000      53,463,000

   Other issuances of common stock ......           243,000          40,000

   Purchases of treasury stock ..........          (187,000)       (751,000)
                                                -----------     -----------
 Weighted average common and common share
   equivalents...........................        47,712,000      52,752,000
                                                ===========     ===========
 Net income  per common share............      $        .41    $        .33
                                                ===========     ===========

</TABLE>
<PAGE>
<TABLE>
 First Health Group Corp. and Subsidiaries
 COMPUTATION OF DILUTED EARNINGS PER COMMON SHARE
 (Unaudited)

                                               Three Months Ended March 31,
                                                ---------------------------
                                                   2000            1999
                                                -----------     -----------
 <S>                                           <C>             <C>
 Net income                                    $ 19,612,000    $ 17,580,000
                                                ===========     ===========
 Weighted average number of common shares
   outstanding:

   Shares outstanding from beginning of period   47,656,000      53,463,000

   Other issuances of common stock ......           243,000          40,000

   Purchases of treasury stock ..........          (187,000)       (751,000)

   Common Stock Equivalents:

   Additional equivalent shares issuable from
     assumed exercise of common stock options     1,819,000         356,000
                                                -----------     -----------
 Weighted average common and common share
   equivalents...........................        49,531,000      53,108,000
                                                ===========     ===========
 Net income per common share.............      $        .40    $        .33
                                                ===========     ===========
</TABLE>
§ 1271.21 When do I register, submit an HCT/P list, and submit updates? ( a ) You must register and submit a list of every HCT/P that your establishment manufactures within 5 days after beginning operations or within 30 days of the effective date of this regulation, whichever is later.
( b ) You must update your establishment registration annually in December, except as required by § 1271.26. You may accomplish your annual registration in conjunction with updating your HCT/P list under paragraph (c) of this section.
( c ) ( i ) If no change described in § 1271.25(c) has occurred since you previously submitted an HCT/P list, you are not required to update your listing.
( ii ) If a change described in § 1271.25(c) has occurred, you must update your HCT/P listing with the new information:
(*a*) At the time of the change, or (*b*) Each June or December, whichever month occurs first after the change. [69 FR 68681, Nov. 24, 2004]
Exhibit 32.2

CERTIFICATION OF CHIEF ACCOUNTING OFFICER

Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 (18 U.S.C. 1350)

The undersigned, Kevin G. Wills, Executive Vice President and Chief Financial Officer of Saks Incorporated
(the Company), has executed this certification in connection with the filing with the Securities and Exchange Commission of the Companys Quarterly Report on Form 10-Q for the quarter ended November 1, 2008 (the
Report).

The undersigned hereby certifies that:



| | 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned has executed this certification as of the 2ndday of December, 2008.



|                                                    
|----------------------------------------------------
|/s/ Kevin G. Wills                                  
|Kevin G. Wills                                      
|Executive Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Saks Incorporated
and will be retained by Saks Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.
|   | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented in the Report. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| March 31, 2011 | By:    | /s/   John P. Broderick     |   |
|----------------|--------|----------------------------------------------------------------|--------|
|           |   | John P. Broderick                                              |   |
|           |   | Chief Executive and Financial Officer                          |   |
|           |   | (Principal Financial and Accounting Officer)                   |   |
#### § 158.3 Definitions.

For the purposes of this part the following definitions shall apply:

(a) *Lot.* A collection of primary containers or units of the same size, type and style manufactured or packed under similar conditions and handled as a single unit of trade.

(b) *Lot size.* The number of primary containers or units (pounds when in bulk) in the lot.

(c) *Sample size.* The total number of sample units drawn for examination from a lot.

(d) *Sample unit.* A container, a portion of the contents of a container, or a composite mixture of product from small containers that is sufficient for the examination or testing as a single unit.

(e) *Defective.* Any sample unit shall be regarded as defective when the sample unit does not meet the criteria set forth in the standards.

(f) *Acceptance number.* The maximum number of defective sample units permitted in the sample in order to consider the lot as meeting the specified requirements. The following acceptance numbers shall apply:

| Lot size (primary container) | Size container | |
| --- | --- | --- |
| *n*1 | *c*2 |
| **net weight equal to or less than 1 kg (2.2 lb)** | | |
| 4,800 or less | 13 | 2 |
| 4,801 to 24,000 | 21 | 3 |
| 24,001 to 48,000 | 29 | 4 |
| 48,001 to 84,000 | 48 | 6 |
| 84,001 to 144,000 | 84 | 9 |
| 144,001 to 240,000 | 126 | 13 |
| Over 240,000 | 200 | 19 |
| **net weight greater than 1 kg (2.2 lb)** | | |
| Number of Pounds | | |
| 20,000 or less | 13 | 2 |
| More than 20,000 to 100,000 | 21 | 3 |
| More than 100,000 to 200,000 | 29 | 4 |
| More than 200,000 to 400,000 | 48 | 6 |
| More than 400,000 to 600,000 | 84 | 9 |
| More than 600,000 to 1,000,000 | 126 | 13 |
| More than 1,000,000 | 200 | 19 |
| | | |
| --- | --- | --- |
| 1 *n* = number of sample units. | | |
| 2 *c* = acceptance number. | | |

(g) *Acceptable quality level* (*AQL*). The maximum percent of defective sample units permitted in a lot that will be accepted approximately 95 percent of the time.

[[42 FR 14461](https://www.federalregister.gov/citation/42-FR-14461), Mar. 15, 1977]
Editorial Note on Part 117
Editorial Note: Nomenclature changes to part 117 appear at 81 FR 49896, July 29, 2016.

§ 117.110 Defect action levels. ( a ) The manufacturer, processor, packer, and holder of food must at all times utilize quality control operations that reduce natural or unavoidable defects to the lowest level currently feasible.
( b ) The mixing of a food containing defects at levels that render that food adulterated with another lot of food is not permitted and renders the final food adulterated, regardless of the defect level of the final food. For examples of defect action levels that may render food adulterated, see the Defect Levels Handbook, which is accessible at*http://www.fda.gov/pchfrule* and at*http://www.fda.gov*.